KALA - Kala Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts5566
Avg. Estimate-0.74-0.71-2.86-1.78
Low Estimate-0.79-0.76-3.03-2.48
High Estimate-0.7-0.69-2.71-0.58
Year Ago EPS-0.6-0.63-2.49-2.86
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts6676
Avg. Estimate2.25M3.48M13.56M64.04M
Low Estimate1M1M4M38.9M
High Estimate3M4.7M20.79M95M
Year Ago SalesN/AN/AN/A13.56M
Sales Growth (year/est)N/AN/AN/A372.30%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.5-0.62-0.52-0.75
EPS Actual-0.6-0.63-0.76-0.75
Difference-0.1-0.01-0.240
Surprise %-20.00%-1.60%-46.20%0.00%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.74-0.71-2.86-1.78
7 Days Ago-0.74-0.73-2.84-2.07
30 Days Ago-0.74-0.73-2.83-2.06
60 Days Ago-0.74-0.73-2.83-2.06
90 Days Ago-0.63-0.62-2.39-1.46
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1113
Up Last 30 Days1114
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1231
Growth EstimatesKALAIndustrySectorS&P 500
Current Qtr.-23.30%N/AN/A0.02
Next Qtr.-12.70%N/AN/A0.04
Current Year-14.90%N/AN/A0.05
Next Year37.80%N/AN/A0.11
Next 5 Years (per annum)37.10%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A